Unknown

Dataset Information

0

The neurobiological basis for novel experimental therapeutics in dystonia.


ABSTRACT: Dystonia is a movement disorder characterized by involuntary muscle contractions, twisting movements, and abnormal postures that may affect one or multiple body regions. Dystonia is the third most common movement disorder after Parkinson's disease and essential tremor. Despite its relative frequency, small molecule therapeutics for dystonia are limited. Development of new therapeutics is further hampered by the heterogeneity of both clinical symptoms and etiologies in dystonia. Recent advances in both animal and cell-based models have helped clarify divergent etiologies in dystonia and have facilitated the identification of new therapeutic targets. Advances in medicinal chemistry have also made available novel compounds for testing in biochemical, physiological, and behavioral models of dystonia. Here, we briefly review motor circuit anatomy and the anatomical and functional abnormalities in dystonia. We then discuss recently identified therapeutic targets in dystonia based on recent preclinical animal studies and clinical trials investigating novel therapeutics.

SUBMITTER: Downs AM 

PROVIDER: S-EPMC6885011 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

The neurobiological basis for novel experimental therapeutics in dystonia.

Downs Anthony M AM   Roman Kaitlyn M KM   Campbell Simone A SA   Pisani Antonio A   Hess Ellen J EJ   Bonsi Paola P  

Neurobiology of disease 20190704


Dystonia is a movement disorder characterized by involuntary muscle contractions, twisting movements, and abnormal postures that may affect one or multiple body regions. Dystonia is the third most common movement disorder after Parkinson's disease and essential tremor. Despite its relative frequency, small molecule therapeutics for dystonia are limited. Development of new therapeutics is further hampered by the heterogeneity of both clinical symptoms and etiologies in dystonia. Recent advances i  ...[more]

Similar Datasets

| S-EPMC4000812 | biostudies-other
| S-EPMC4425266 | biostudies-literature
| S-EPMC3823891 | biostudies-literature
| S-EPMC5673689 | biostudies-other
| S-EPMC7533999 | biostudies-literature
| S-EPMC6873901 | biostudies-literature
| S-EPMC5042200 | biostudies-literature
| S-EPMC6519462 | biostudies-literature
| S-EPMC3360987 | biostudies-literature
| S-EPMC6999209 | biostudies-literature